These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22898640)

  • 1. The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.
    Hillion J; Smail SS; Di Cello F; Belton A; Shah SN; Huso T; Schuldenfrei A; Nelson DM; Cope L; Campbell N; Karikari C; Aderinto A; Maitra A; Huso DL; Resar LM
    Pancreatology; 2012; 12(4):372-9. PubMed ID: 22898640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
    Liau SS; Rocha F; Matros E; Redston M; Whang E
    Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase inhibitors block uterine tumorigenesis in HMGA1a transgenic mice and human xenografts.
    Di Cello F; Hillion J; Kowalski J; Ronnett BM; Aderinto A; Huso DL; Resar LM
    Mol Cancer Ther; 2008 Jul; 7(7):2090-5. PubMed ID: 18645019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma.
    Liau SS; Jazag A; Whang EE
    Cancer Res; 2006 Dec; 66(24):11613-22. PubMed ID: 17178855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas.
    Yip-Schneider MT; Barnard DS; Billings SD; Cheng L; Heilman DK; Lin A; Marshall SJ; Crowell PL; Marshall MS; Sweeney CJ
    Carcinogenesis; 2000 Feb; 21(2):139-46. PubMed ID: 10657949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models.
    Trapasso F; Sarti M; Cesari R; Yendamuri S; Dumon KR; Aqeilan RI; Pentimalli F; Infante L; Alder H; Abe N; Watanabe T; Viglietto G; Croce CM; Fusco A
    Cancer Gene Ther; 2004 Sep; 11(9):633-41. PubMed ID: 15272314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma.
    Liau SS; Whang E
    Clin Cancer Res; 2008 Mar; 14(5):1470-7. PubMed ID: 18316571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
    Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
    PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells.
    Sharma P; Yadav P; Jain RP; Bera AK; Karunagaran D
    Life Sci; 2022 Feb; 291():120268. PubMed ID: 34973275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.
    Raut CP; Nawrocki S; Lashinger LM; Davis DW; Khanbolooki S; Xiong H; Ellis LM; McConkey DJ
    Cancer Biol Ther; 2004 Dec; 3(12):1217-24. PubMed ID: 15477758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors.
    Ding X; Zhu C; Qiang H; Zhou X; Zhou G
    Biomed Pharmacother; 2011 Oct; 65(7):486-90. PubMed ID: 21993002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enhancing effects of celecoxib on the growth inhibition of pancreatic carcinoma by gemcitabine treatment].
    Xu G; Wu K; Wang XP; Zhao S
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):986-91. PubMed ID: 16060994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non‑coding RNA LINC01748 exerts carcinogenic effects in non‑small cell lung cancer cell lines by regulating the microRNA‑520a‑5p/HMGA1 axis.
    Tan Y; Xu F; Xu L; Cui J
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34970695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
    Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
    Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer.
    Fu SL; Wu YL; Zhang YP; Qiao MM; Chen Y
    World J Gastroenterol; 2004 Jul; 10(13):1971-4. PubMed ID: 15222049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of celecoxib pharmacodynamics in pancreatic cancer.
    Jimeno A; Amador ML; Kulesza P; Wang X; Rubio-Viqueira B; Zhang X; Chan A; Wheelhouse J; Kuramochi H; Tanaka K; Danenberg K; Messersmith WA; Almuete V; Hruban RH; Maitra A; Yeo CJ; Hidalgo M
    Mol Cancer Ther; 2006 Dec; 5(12):3240-7. PubMed ID: 17172427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
    Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of HMGA1 expression by RNA interference suppresses growth of osteogenic sarcoma.
    Yuan S; Pan Q; Fu C; Bi Z
    Mol Cell Biochem; 2011 Sep; 355(1-2):281-7. PubMed ID: 21573994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.
    Tesfaye A; Di Cello F; Hillion J; Ronnett BM; Elbahloul O; Ashfaq R; Dhara S; Prochownik E; Tworkoski K; Reeves R; Roden R; Ellenson LH; Huso DL; Resar LM
    Cancer Res; 2007 May; 67(9):3998-4004. PubMed ID: 17483309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.